“A Randomized, Parallel-Group, Open-Label, Multicenter Study to Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing with a New Lower-Concentration (0.025%) Clobetasol Propionate Cream”, J of Skin, vol. 2, p. S83, Dec. 2018, doi: 10.25251/skin.2.supp.84.